You are here: Industry Insights > cancer

News List

Janssen debuts promising new cancer data at ASCO pharmafile
June 07, 2018
Janssen took the opportunity at the American Society of Clinical Oncology (ASCO) annual event to present promising new Phase 2 and 3 data on two of its candidates
Trial to test cancer combo in both adults and children pharmatimes
June 06, 2018
UK researchers have launched an early stage trial designed to help assess whether AstraZeneca and MSD’s selumetinib could be effective in combination with dexamethasone as a treatment for leukaemia.
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation worldpharmanews
June 05, 2018
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.
Tiny particles could help fight brain cancer worldpharmanews
June 05, 2018
Glioblastoma multiforme, a type of brain tumor, is one of the most difficult-to-treat cancers. Only a handful of drugs are approved to treat glioblastoma
Agendia and Angsana to Provide Breast Cancer Risk-of-Recurrence Testing with MammaPrint® and BluePrint® to Patients in Southeast Asia b3cnewswire.
June 04, 2018
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, and Angsana Molecular & Diagnostics Laboratory Pte Ltd, a subsidiary of Parkway Pantai
Shuwen Biotech, Bliss pharma unite for companion diagnostics of cancer biospectrumasia
May 29, 2018
Companion diagnostics and precision medicine are Shuwen’s major focus
Merck's Keytruda, Roche's Tecentriq may lag chemo in some cancer patients, FDA says fiercepharma
May 23, 2018
Merck and Roche’s immunotherapies are each approved solo for certain previously untreated bladder cancer patients. But for other frontline patients, the drugs may be hurting their survival chances.
Innovative light-delivery technique improves biosensors europeanpharmaceuticalreview
May 23, 2018
An innovative way to inject light into tiny silicon microdisks could help meet the need for practical chip-based sensors to detect cancer and other diseases.
Accent Therapeutics to provide precision cancer treatments biospectrumasia
May 22, 2018
Accent Therapeutics targets cancer-linked RNA-modifying proteins with precision therapies to translate extraordinary science into life-changing therapies for patients.
New cancer immunotherapy drugs rapidly reach patients after approval europeanpharmaceuticalreview
May 15, 2018
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page